Delivery Order SPE2DB22D3004-SPE2DB25FQB37

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,968.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of EMERPHED 50 MG/10 ML SYRINGE 10ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 9, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,470.43 firm fixed-price delivery order is for the supply of EMERPHED 50 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of May 7, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,228.40, is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The contract is for the supply of EMERPHED 50 MG/10 ML VIAL 10ML, a pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,112.76, is for the delivery of EMERPHED 50 MG/10 ML VIAL 10ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 20, 2025. The contract was awarded on March 19, 2025 and does not have a set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,893.93, is for the delivery of EMERPHED 25 MG/5 ML SYRINGE 5ML, a medical product. The contract is a Firm Fixed Price Delivery Order with a completion date of May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
This is a federal contract award valued at $2,952.27 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide 4564287327 - EMERPHED 50 MG/10 ML SYRINGE 10ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an Ultimate Completion Date of April 16, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,832.78, is for the delivery of EMERPHED 50 MG/10 ML VIAL 10ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of January 2, 2025. This award is not associated with a set-aside designation. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,357.44 Firm Fixed Price Delivery Order (SPE2DB22D3004|SPE2DB25FNX72) is for the supply of EMERPHED 50 MG/10 ML SYRINGE 10ML, a pharmaceutical product. The contract has an ultimate completion date of December 24, 2024. Amerisourcebergen maintains a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EMERPHED 25 MG/5 ML SYRINGE 5ML. The contract has a Ceiling Value of $3,825.10 and a completion date of April 25, 2023. This award is a Firm Fixed Price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,114.73 firm fixed-price delivery order is for the medication EMERPHED 50 MG/10 ML VIAL 10ML, with a performance period through May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQB37
    Delivery Order

This federal contract award, valued at $1,102.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMERPHED 50 MG/10 ML SYRINGE 10ML, a medical product, with a completion date of March 28, 2025.

The award is not designated as a set-aside contract. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/26/25, 10:16 AM